Chemours Q3 net income $60M vs loss prior year; adjusted EBITDA $195M down 3%

Chemours Co

2025-Q3 EPS reported -$2.16 revenue$4,478,000,000

Net income of $60M ($0.40/share) reverses prior-year loss of $32M; adjusted net income $30M ($0.20) vs $61M.
Revenue $1.5B flat YoY; TSS Opteon refrigerants grew 80% YoY, offset by APM Washington Works outage.
Adjusted EBITDA $195M down 3% YoY; management says consolidated results exceeded expectations.
Announced global TiO2 price increase effective Dec 1, 2025; strategic agreement with SRF Limited in India.
Qualified two-phase immersion cooling fluid with Samsung Electronics for data center applications.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.